Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual firms.

Gaps are information. They are the place on the chart where you can see buyers and sellers jumping ahead to a fast repricing, ...

Franklin Biotechnology Discovery has a much higher 13% five-year annualized return than a biotech index ETF’s 5.3% ...

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual ...

These biotech stocks all popped after their recent earnings reports. All three have outperformed 97% of stocks in the last 12 ...

In this article, we will take a look at some of the best AI driven biotech stocks that are currently offering attractive upside potential. On June 4, CNBC reported that global biopharma mergers and ...

Looking for the latest stock opportunities in August 2026? We have you covered. Click to read our top stock picks to consider adding to your portfolio now.

JNJ, MRK, and AMGN use AI to speed drug discovery, beat the market, and pay dividends. See the top AI healthcare pick for 2026.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CRISPR Therapeutics is a gene editing specialist. It developed Casgevy, a medicine for two rare blood diseases, in collaboration with Vertex Pharmaceuticals. Casgevy doesn't generate much revenue yet, ...